Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 141,055 |
|
|||||
| News | - | ||||||
| Day High | 14.77 | Low High |
|||||
| Day Low | 13.80 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Alto Neuroscience Inc | ANRO | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.08 | 0.56% | 14.30 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.37 | 13.80 | 14.77 | 14.30 | 14.22 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,794 | 141,055 | US$ 13.98 | US$ 1,972,033 | - | 12.7798 - 24.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:00:00 | 2,136 | US$ 14.30 | USD |
Alto Neuroscience Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 382.35M | 26.79M | - | 0 | -36.31M | -1.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alto Neuroscience News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/23/2024 | 07:05 | Business Wire | Alto Neuroscience Announces Positive Phase 1 Results for.. |
| 4/03/2024 | 07:05 | Business Wire | Alto Neuroscience Announces Initiation of Phase 2 Study of.. |
| 3/21/2024 | 15:05 | Business Wire | Alto Neuroscience Reports Full Year 2023 Financial Results.. |
| 3/11/2024 | 07:05 | Business Wire | Alto Neuroscience Appoints Maha Radhakrishnan, M.D., to.. |
| 3/07/2024 | 07:00 | Business Wire | Alto Neuroscience to Participate in Upcoming Investor.. |
| 2/27/2024 | 07:00 | Business Wire | Alto Neuroscience to Present at the TD Cowen 44th Annual.. |
| 2/06/2024 | 15:05 | Business Wire | Alto Neuroscience Announces Closing of Upsized Initial.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANRO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.36 | 16.535 | 13.80 | 15.17 | 92,354 | -0.06 | -0.42% |
| 1 Month | 14.69 | 16.535 | 12.7798 | 14.13 | 89,317 | -0.39 | -2.65% |
| 3 Months | 17.08 | 18.3499 | 12.7798 | 14.84 | 198,695 | -2.78 | -16.28% |
| 6 Months | 22.00 | 24.00 | 12.7798 | 15.97 | 231,149 | -7.70 | -35.00% |
| 1 Year | 22.00 | 24.00 | 12.7798 | 15.97 | 231,149 | -7.70 | -35.00% |
| 3 Years | 22.00 | 24.00 | 12.7798 | 15.97 | 231,149 | -7.70 | -35.00% |
| 5 Years | 22.00 | 24.00 | 12.7798 | 15.97 | 231,149 | -7.70 | -35.00% |
Alto Neuroscience Description
| Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. |
